Cargando…

Mechanism and Therapeutic Opportunities of Histone Modifications in Chronic Liver Disease

Chronic liver disease (CLD) represents a global health problem, accounting for the heavy burden of disability and increased health care utilization. Epigenome alterations play an important role in the occurrence and progression of CLD. Histone modifications, which include acetylation, methylation, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Qiuyu, Gan, Can, Tang, Chengwei, Wu, Hao, Gao, Jinhang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650224/ https://www.ncbi.nlm.nih.gov/pubmed/34887768 http://dx.doi.org/10.3389/fphar.2021.784591

Ejemplares similares

Inflammasomes and Pyroptosis of Liver Cells in Liver Fibrosis
por: Gan, Can, et al.
Publicado: (2022)

Circular RNA as an Epigenetic Regulator in Chronic Liver Diseases
por: Zeng, Xianhui, et al.
Publicado: (2021)

Histone modification and histone modification-targeted anti-cancer drugs in breast cancer: Fundamentals and beyond
por: Feng, Jianwei, et al.
Publicado: (2022)

The Impact of Histone Modifications in Endometriosis Highlights New Therapeutic Opportunities
por: Psilopatis, Iason, et al.
Publicado: (2023)

Fatty Acid β-Oxidation in Kidney Diseases: Perspectives on Pathophysiological Mechanisms and Therapeutic Opportunities
por: Gao, Zhumei, et al.
Publicado: (2022)

PARP-1: a critical regulator in radioprotection and radiotherapy-mechanisms, challenges, and therapeutic opportunities
por: Li, Wen-Hao, et al.
Publicado: (2023)

Editorial: Ferroptosis as new therapeutic targets in cancer: From molecular mechanisms to therapeutic opportunities
por: Chen, Jian, et al.
Publicado: (2022)

The interaction between cellular senescence and chronic kidney disease as a therapeutic opportunity
por: Zhao, Jing-Li, et al.
Publicado: (2022)

Potential therapeutic strategies for quercetin targeting critical pathological mechanisms associated with colon adenocarcinoma and COVID-19
por: Li, Xiushen, et al.
Publicado: (2022)

Therapeutic Opportunities of GPBAR1 in Cholestatic Diseases
por: Zhang, Fangling, et al.
Publicado: (2022)

Histone Methyltransferases as Therapeutic Targets for Kidney Diseases
por: Yu, Chao, et al.
Publicado: (2019)

Editorial: Epigenetic mechanisms and post-translational modifications as novel therapeutic targets in cancer
por: Shi, Zhi, et al.
Publicado: (2022)

Post‐translational modifications of histones: Mechanisms, biological functions, and therapeutic targets
por: Liu, Ruiqi, et al.
Publicado: (2023)

Inhibition of Transketolase Improves the Prognosis of Colorectal Cancer
por: Zhang, Linhao, et al.
Publicado: (2022)

Histone Modification in NSCLC: Molecular Mechanisms and Therapeutic Targets
por: Bajbouj, Khuloud, et al.
Publicado: (2021)

High Throughput mRNA Sequencing Reveals Potential Therapeutic Targets of Tao-Hong-Si-Wu Decoction in Experimental Middle Cerebral Artery Occlusion
por: Duan, Xianchun, et al.
Publicado: (2019)

The Role of Nrf2 in Liver Disease: Novel Molecular Mechanisms and Therapeutic Approaches
por: Xu, Dongwei, et al.
Publicado: (2019)

Molecular Mechanisms and Potential New Therapeutic Drugs for Liver Fibrosis
por: Wang, Fa-Da, et al.
Publicado: (2022)

The Role and Mechanism of Histone Deacetylases in Acute Kidney Injury
por: Zhou, Xun, et al.
Publicado: (2021)

Editorial: Chronic Liver Disease: New Targets and New Mechanisms
por: Ye, Yanting, et al.
Publicado: (2022)

Editorial: Chronic Liver Disease: New Targets and New Mechanisms, Volume II
por: Jerez, Sofia, et al.
Publicado: (2023)

Challenges and Opportunities for Therapeutic Targeting of Calmodulin Kinase II in Heart
por: Nassal, Drew, et al.
Publicado: (2020)

Possible Role of Adenosine in COVID-19 Pathogenesis and Therapeutic Opportunities
por: Geiger, Jonathan D., et al.
Publicado: (2020)

Crosstalk of Histone and RNA Modifications Identified a Stromal-Activated Subtype with Poor Survival and Resistance to Immunotherapy in Gastric Cancer
por: Yuan, Cheng, et al.
Publicado: (2022)

The Application of Cell-Free Protein Synthesis in Genetic Code Expansion for Post-translational Modifications
por: Venkat, Sumana, et al.
Publicado: (2019)

Accelerating Therapeutics for Opportunities in Medicine: A Paradigm Shift in Drug Discovery
por: Hinkson, Izumi V., et al.
Publicado: (2020)

Inhibition of 5-Lipoxygenase in Hepatic Stellate Cells Alleviates Liver Fibrosis
por: Pu, Shiyun, et al.
Publicado: (2021)

Histone Deacetylase 6 as a Therapeutic Target in B cell-associated Hematological Malignancies
por: Yang, Jia, et al.
Publicado: (2020)

The Potential Application of Chinese Medicine in Liver Diseases: A New Opportunity
por: Fu, Ke, et al.
Publicado: (2021)

The Histone Deacetylase Inhibitor I1 Induces Differentiation of Acute Leukemia Cells With MLL Gene Rearrangements via Epigenetic Modification
por: Yao, Jingfang, et al.
Publicado: (2022)

Atypical cholangiocytes derived from hepatocyte-cholangiocyte transdifferentiation mediated by COX-2: a kind of misguided liver regeneration
por: Lan, Tian, et al.
Publicado: (2023)

Uncovering the Anticancer Mechanisms of Chinese Herbal Medicine Formulas: Therapeutic Alternatives for Liver Cancer
por: Chen, Feiyu, et al.
Publicado: (2020)

Editorial: Advances in non-alcoholic fatty liver disease therapeutics: Pathogenic mechanisms and targets
por: Blas-García, Ana, et al.
Publicado: (2022)

Therapeutic effect and metabolomics mechanism of Patrinia Villosa (Thunb.) juss on liver injury in rats
por: Qiao, Li-Man, et al.
Publicado: (2022)

The Role of Chemokines in Mediating Graft Versus Host Disease: Opportunities for Novel Therapeutics
por: Castor, Marina G. M., et al.
Publicado: (2012)

Arginase Pathway in Acute Retina and Brain Injury: Therapeutic Opportunities and Unexplored Avenues
por: Fouda, Abdelrahman Y., et al.
Publicado: (2020)

Exploring the Critical Components and Therapeutic Mechanisms of Perilla frutescens L. in the Treatment of Chronic Kidney Disease via Network Pharmacology
por: Yong, Chen, et al.
Publicado: (2021)

Liver Fibrosis Resolution: From Molecular Mechanisms to Therapeutic Opportunities
por: Pei, Qiying, et al.
Publicado: (2023)

The pathogenesis of liver cancer and the therapeutic potential of bioactive substances
por: Gao, Song, et al.
Publicado: (2022)

Betaine attenuates chronic alcohol-induced fatty liver by broadly regulating hepatic lipid metabolism
por: Yang, Wenjuan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_cskhggi6a7p4s6fkitaqfoh8o3